Navigation Links
MARC Travel Awards announced for the 22nd American Peptide Symposium
Date:5/11/2011

Bethesda, MD FASEB MARC (Minority Access to Research Careers) Program has announced the travel award recipients for the 22nd American Peptide Symposium to be held in San Diego, CA from June 25-30, 2011. These awards are meant to promote the entry of underrepresented minority students, postdoctorates and scientists into the mainstream of the basic science community and to encourage the participation of young scientists at the 22nd American Peptide Symposium.

Awards are given to poster/platform presenters and faculty mentors paired with the students/trainees they mentor. This year MARC conferred 3 awards totaling $4,950.

The FASEB MARC Program is funded by a grant from the National Institute of General Medical Sciences, National Institutes of Health. A primary goal of the MARC Program is to increase the number and competitiveness of underrepresented minorities engaged in biomedical and behavioral research.

FACULTY/MENTOR & STUDENTS/MENTEES (FASEB MARC PROGRAM)

Dr. Nadeem Fazal, Chicago State University [AAI member]
Alla Shelip, Chicago State University
Erum Siddiqui, Chicago State University


'/>"/>

Contact: Fran Yates
fyates@faseb.org
301-634-7109
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. MARC travel awards announced for GSA Mouse Genetics Conference
2. MARC Travel awards announced for the Endocrine Societys 93rd Annual Meeting and Expo
3. MARC Travel Award announced for ISCB Great Lakes Bioinformatics Conference
4. MARC travel awards announced for Immunology 2011
5. 2011 PerkinElmer Signature Genomic Laboratories Travel Award winner announced
6. MARC Travel Awards announced for GSA 26th Fungal Genetics Meeting
7. Joshua E. Neimark Memorial Travel Assistance Award winners investigate stem cell transplantation, sustainable growth, women in academia, and conservation science
8. MARC Travel awards announced for the 2011 ACSM Texas Chapter Annual Meeting
9. MARC Travel awards announced for the 2011 ACSM Southeast Chapter Annual Meeting
10. DNA engine observed in real-time traveling along base pair track
11. Biophysical Society announces winners of 2011 Student Travel Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2016)...  Syngrafii Inc. and San Antonio Credit Union ... integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution into ... result in greater convenience for SACU members and ... existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/2/2016)... , June 2, 2016   The Weather Company , ... Watson Ads, an industry-first capability in which consumers will be ... able to ask questions via voice or text and receive ... Marketers have long sought an advertising ... that can be personal, relevant and valuable; and can scale ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology: